After completion of his medical education and cardiology training in the US, Dr. Broberg did his ACHD training at the Royal Brompton Hospital in London before returning to Portland to be Director of the ACHD program at Oregon Health and Science University. He has maintained an active research agenda since, with funding from the National Institutes of Health and the American Heart Association. His work has primarily focused on mechanisms of myocardial dysfunction in ACHD. As well he has been a founding member of the Alliance for Adult Research in Congenital Cardiology, producing multicentre ACHD research in North America.
Myocardial dysfunction is a final common pathway in a number of ACHD conditions. An important marker and precursor of this is myocardial fibrosis, detectable with cardiac magnetic resonance. This talk with explore what is now known about fibrosis, its aetiology, its downstream consequences, and how it may direct our efforts to treat myocardial dysfunction.